Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
555,826,183
-
Share change
-
-12,673,892
-
Total reported value
-
$5,503,173,470
-
Put/Call ratio
-
126%
-
Price per share
-
$9.90
-
Number of holders
-
418
-
Value change
-
-$133,814,474
-
Number of buys
-
157
-
Number of sells
-
176
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2021
As of 30 Jun 2021 TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) had 418 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 555,826,183 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, Capital World Investors, Berkshire Hathaway Inc, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., Migdal Insurance & Financial Holdings Ltd., STATE STREET CORP, MENORA MIVTACHIM HOLDINGS LTD., Clal Insurance Enterprises Holdings Ltd, and Phoenix Holdings Ltd..
This table shows 422 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.